Long Term Exendin-4 Treatment Reduces Food Intake and Body Weight and Alters Expression of Brain Homeostatic and Reward Markers

Repeated administration of the long-acting glucagon-like peptide 1 receptor agonist exendin-4 (EX-4) has been shown to reduce food intake and body weight and do so without a rebound increase in food intake after treatment termination. The current study examines the neural mechanisms underlying these...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Yang, Yan, Moghadam, Alexander A., Cordner, Zachary A., Liang, Nu-Chu, Moran, Timothy H.
Format: Artigo
Idioma:Inglês
Publicat: Endocrine Society 2014
Matèries:
Energy Balance-Obesity
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4138563/
https://ncbi.nlm.nih.gov/pubmed/24949661
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2014-1052
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars